Literature DB >> 30222454

Patient Engagement by Pharma-Why and How? A Framework for Compliant Patient Engagement.

Lode Dewulf1.   

Abstract

Engagement is increasingly recognized as a decisive factor for health-related outcomes in people living with a medical issue. It is their experience that drives this engagement. Therefore, providers who seek to develop better solutions, including medicines, must gain a deeper understanding of the patient experience. Beyond pathology, such understanding requires direct engagement with patients, something that has been historically avoided in the pharmaceutical industry. Whereas clear and comprehensive engagement frameworks are in place for direct engagement with health care professionals, such guidance does not yet exist for engagement with patients. A patient engagement framework has been developed at UCB to fill this gap, and it is herewith shared publicly as a contribution to setting and raising standards in patient engagement, with the ultimate aim of fostering the development of better solutions for people living with medical issues.

Entities:  

Keywords:  engagement; framework; insights; patient; privacy

Year:  2015        PMID: 30222454     DOI: 10.1177/2168479014558884

Source DB:  PubMed          Journal:  Ther Innov Regul Sci        ISSN: 2168-4790            Impact factor:   1.778


  7 in total

1.  Culture and Process Change as a Priority for Patient Engagement in Medicines Development.

Authors:  Marc Boutin; Lode Dewulf; Anton Hoos; Jan Geissler; Veronica Todaro; Roslyn F Schneider; Vincenzo Garzya; Andrew Garvey; Paul Robinson; Tonya Saffer; Sarah Krug; Ify Sargeant
Journal:  Ther Innov Regul Sci       Date:  2016-08-20       Impact factor: 1.778

2.  Patient involvement in preparing health research peer-reviewed publications or results summaries: a systematic review and evidence-based recommendations.

Authors:  Lauri Arnstein; Anne Clare Wadsworth; Beverley Anne Yamamoto; Richard Stephens; Kawaldip Sehmi; Rachel Jones; Arabella Sargent; Thomas Gegeny; Karen L Woolley
Journal:  Res Involv Engagem       Date:  2020-06-24

3.  Utilizing patient advocates in Parkinson's disease: A proposed framework for patient engagement and the modern metrics that can determine its success.

Authors:  Megan Feeney; Christiana Evers; Danielle Agpalo; Lisa Cone; Jori Fleisher; Karlin Schroeder
Journal:  Health Expect       Date:  2020-05-03       Impact factor: 3.377

4.  What do stakeholders expect from patient engagement: Are these expectations being met?

Authors:  Mathieu Boudes; Paul Robinson; Neil Bertelsen; Nicholas Brooke; Anton Hoos; Marc Boutin; Jan Geissler; Ify Sargeant
Journal:  Health Expect       Date:  2018-06-01       Impact factor: 3.377

5.  An Evolved Approach to Advisory Boards in Rare Disease Drug Development: 5-Step Model to Finding and Engaging Patient Advisors.

Authors:  Carlotta Dillon; Joyce Knapp; Mark Stinson
Journal:  J Patient Exp       Date:  2020-10-26

6.  Patient Involvement in the Lifecycle of Medicines According to Belgian Stakeholders: The Gap Between Theory and Practice.

Authors:  Rosanne Janssens; Eline van Overbeeke; Lotte Verswijvel; Lissa Meeusen; Carolien Coenegrachts; Kim Pauwels; Marc Dooms; Hilde Stevens; Steven Simoens; Isabelle Huys
Journal:  Front Med (Lausanne)       Date:  2018-10-11

7.  Optimising Multi-stakeholder Practices in Patient Engagement: A Gap Analysis to Enable Focused Evolution of Patient Engagement in the Development and Lifecycle Management of Medicines.

Authors:  S D Faulkner; C A C M Pittens; N S Goedhart; E H Davies; E Manning; A Diaz-Ponce; Maria Jose Vicente Edo; L Prieto-Remón; L Husain; K Huberman; M Boudes; M Subramaniam
Journal:  Ther Innov Regul Sci       Date:  2021-06-28       Impact factor: 1.778

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.